Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2026-03-22 @ 6:12 AM
Study NCT ID:
NCT03534635
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-21
First Post:
2018-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Analysis of the Modulation of the Tumor Microenvironment by MK-3475 (Pembrolizumab) Using a Systems Biology Approach (PEMSYS)
Sponsor:
Centre Hospitalier Universitaire Vaudois
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CHUV-DO-PEMSYS_2017
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None